SSSvetlana Solovieva

Svetlana Solovieva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Svetlana Solovieva has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mycoplasma pneumonia: Modern antibacterial therapy

    by N. B. Lazareva, S. S. Solovieva, A. S. Ermolaeva, M. E. Andreeva

    Mycoplasma pneumoniae (M. pneumoniae) is one of the key pathogens causing the community-acquired pneumonia in all countries, especially in children and adolescents. Globally, M. pneumoniae infections occur in different regions of the world every 3–7 years and last 1–2 years. M. pneumoniae has infective factors characterized by high affinity to the epithelial cells of the respiratory tract, direct damaging effect, as well as ability to interact with immune system cells. The pathogenesis of mycoplasma infection, i.e. pneumonia, includes both direct damage and immune response mediated by vasculitis and thrombosis. Macrolides are used as the main class of antibiotics for the treatment of mycoplasma infection. They inhibit bacterial growth by binding to 23S rRNA and inhibiting protein synthesis. However, macrolide-resistant strains of M. pneumoniae (MRMP) have become widespread in Asia since 2000, accounting for about 80–90% infections in China and Japan today, at the same time, the detection rate of MRMP is very low in European countries and the US. Azithromycin and clarithromycin have high bioavailability, are stable at acidic pH, oral forms do not require intestinal coating. Instant soluble drug forms (azithromycin) and suspension can be used by patients regardless of food intake, which ensures convenience. While the slow released drug forms of azithromycin should be taken only on an empty stomach, the slow released extended forms of clarithromycin should be taken with food.

  • Skin alterations as possible clinical markers of diabetes mellitus and metabolic syndrome

    by A.A. Gazdanova, N.I. Lenkova, O.V. Ryazantseva, Z.T. Astakhova, A.S. Sivkov, A.V. Perkov, S.A. Knyazeva, S.A. Solovieva, A.S. Plieva

    The review presents data on skin changes (acanthosis nigricans, xeroderma, scleredema, diabetic rubeosis, diabetic dermopathy, necrobiosis lipoidica, etc.) occurring in diabetes mellitus and other components of the metabolic syndrome. Some common potential mechanisms of development of metabolic syndrome and skin diseases such as psoriasis, acne vulgaris, hidradenitis suppurativa, androgenetic alopecia, acanthosis nigricans and atopic dermatitis are discussed. Skin manifestations may be signs of insulin resistance and impairment glucose tolerance, xanthomas and xanthelasmas are sings of dyslipidemia. Psoriasis and hidradenitis suppurativa are often associated with metabolic syndrome and obesity. Acne, hirsutism and androgenetic alopecia are widely signs of hyperandrogenism. A better understanding of correlation between metabolic syndrome and skin diseases contributes to early diagnosis and prevention, as well as provides the key to develop new therapeutic strategies. Primary care physicians, as well as dermatovenerologists and cosmetologists can play a key role in early detection and therefore earlier treatment of metabolic syndrome, contributing to the reduction of the associated with this pathological syndrome cardiovascular risk.

  • SKIN Disorders in the pathology of the digestive organs and malabsorption syndrome in general medical practice

    by Gazdanova A.A. Gazdanova, Lenkova N.I. Lenkova, Ryazantseva O.V. Ryazantseva, Solovieva S.A. Solovieva, I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University

  • Examination of the oral cavity as an important diagnostic tool of a primary care physician

    by Gazdanova A.A. Gazdanova, Plieva A.S. Plieva, Solovieva S.A. Solovieva, Ponomarenko T.M. Ponomarenko, I.I. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University, Vladikavkaz North Ossetian State Medical Academy Of The Ministry Of Healthcare Of Russia

  • Open Access

    Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea

    by V.N. Drozdov, E.V. Shikh, A.A. Astapovskiy, K.N. Khalaidzheva, S.а. Solovieva, O.B. Dorogun

    Клиническая эффективность современного пробиотика для коррекции кишечной микрофлоры у пациентов с синдромом раздраженного кишечника с диареей и c


  • Inspection of the skin and its additives: relevance in the diagnostics of endocrine diseases

    by Gazdanova A.A. Gazdanova, Lenkova N.I. Lenkova, Ryazantseva O.V. Ryazantseva O, Solovieva S.A. Solovieva, Sivkov A.S. Sivkov, Knyazeva S.A. Knyazeva, Plieva A.S. Plieva A, I.I. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University, Vladikavkaz North Ossetian State Medical Academy Of The Ministry Of Healthcare Of Russia


  • Open Access

    Contribution of compositional changes in the workforce to sickness absence trends in Finland

    by T Leinonen, E Hartikainen, L Salonen, E Viikari-Juntura, S Solovieva

    Background: Information on factors driving work disability trends helps to evaluate the potential of interventions to improve the health and work ability of the workforce. We assessed whether the long-term decrease in sickness absences in Finland is explained by observed and unobserved compositional changes in the workforce. Methods: Utilising register-based panel data on Finnish private and public sector employees aged 30-62, we examined the annual onset of compensated full sickness absence (granted after 10 working days) in the period 2005-2016. We applied random effects models adjusting for changes in observed sociodemographic factors of the study population. We also applied fixed effects models, with corrections of the estimates for cohort ageing, to additionally account for unobserved time-invariant characteristics of the study population over the years. Results: Of the observed factors, increases in educational level partly explained the decreasing trend in sickness absences, and more so among women than men and among private than public sector employees. Changes in occupational class and industrial sector played little role in the public sector and only slightly further explained the sickness absence trend in the private sector. The decreasing trend in sickness absences appeared to be largely explained by unobserved time-invariant individual characteristics. Conclusions: The decrease in sickness absences appeared to be more strongly influenced by compositional changes in factors that are established before fully entering the labour market - such as educational level as well as unmeasured individual characteristics that remain unchanged after childhood and early adulthood - than in the work environment or other factors contributing at working age. Attempts to improve the health and work ability of the workforce should not only rely on interventions directed at the working age population, but also on those carried out early during the life course. Key messages: • Compositional changes in the workforce should be taken into account when assessing sickness absence trends. • Interventions aiming to improve the health and work ability of the workforce should be implemented already early in the life course and not only in working age.

  • Dental manifestations of somatic diseases

    by A.A. Gazdanova, T.M. Ponomarenko, S.A. Solovieva, N.I. Lenkova, O.V. Ryazantseva, A.S. Sivkov, A.S. Deryugin, E.E. Andreeva

    Изменения зубов, десен и слизистой оболочки полости рта часто встречаются при соматических заболеваниях и могут быть первыми и в течение более или менее длительного времени единственными проявлениями единого системного патологического процесса, а также показателем активности заболевания. В обзоре систематизированы и подробно рассмотрены стоматологические проявления при заболеваниях органов дыхания и сердечно-сосудистой системы, желудочно-кишечного тракта и гепатобилиарной системы, кроветворной и эндокринной систем, почек, ревматических заболеваниях. Знание стоматологических проявлений внутренних болезней повышает эффективность междисциплинарного взаимодействия между стоматологами и терапевтами, целью которого является повышение эффективности диагностики и, следовательно, лечения больных с данной патологией.


  • Open Access

    Synergism of components as the main approach to creation of a probiotic complex

    by E. V. Shikh, S. A. Solovieva, A. V. Perkov

    Синергизм компонентов как основной подход к формированию пробиотического комплекса